460
Participants
Start Date
January 3, 2025
Primary Completion Date
April 30, 2026
Study Completion Date
May 31, 2026
HDM1702
Initiate at a once weekly dose of 0.25 mg and followed a fixed-dose escalation regimen, with dose increases every 4 weeks (to doses of 0.5, 1.0, 1.7 and 2.4 mg per week) aiming at reaching the maintenance dose of 2.4 mg at week 16.
Wegovy ®
Initiate at a once weekly dose of 0.25 mg and followed a fixed-dose escalation regimen, with dose increases every 4 weeks (to doses of 0.5, 1.0, 1.7 and 2.4 mg per week) aiming at reaching the maintenance dose of 2.4 mg at week 16.
RECRUITING
Peking University People's Hospital, Beijing
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
INDUSTRY